Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
N/A
-18,889 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
N/A
-1,500 Reduced 7.36%
18,889 $93,000
Q1 2021

Apr 14, 2021

BUY
N/A
300 Added 1.49%
20,389 $98,000
Q4 2020

Feb 04, 2021

SELL
N/A
-955 Reduced 4.54%
20,089 $87,000
Q3 2020

Oct 26, 2020

BUY
N/A
21,044 New
21,044 $0
Q1 2020

May 08, 2020

SELL
N/A
-4,920 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
N/A
4,920 New
4,920 $0
Q4 2018

Feb 11, 2019

SELL
N/A
-12,530 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
N/A
-3,240 Reduced 20.55%
12,530 $222,000
Q2 2018

Aug 03, 2018

BUY
N/A
370 Added 2.4%
15,770 $407,000
Q1 2018

May 01, 2018

BUY
N/A
15,400 New
15,400 $368,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.